The impact of thyroid hormones on patients with hepatocellular carcinoma

Autor: Wolfgang Sieghart, F. Hucke, Simona Bota, Matthias Pinter, Lukas Haupt, Michael Trauner, Theresa Bucsics, Markus Peck-Radosavljevic
Rok vydání: 2017
Předmět:
Oncology
Male
RNA viruses
Etiology
Peptide Hormones
Thyroid Gland
lcsh:Medicine
Hepacivirus
Thyroid Function Tests
Biochemistry
0302 clinical medicine
Endocrinology
Mathematical and Statistical Techniques
Medicine and Health Sciences
lcsh:Science
10. No inequality
Pathology and laboratory medicine
Aged
80 and over

Thyroid
Univariate analysis
Multidisciplinary
medicine.diagnostic_test
Hepatitis C virus
Liver Diseases
Liver Neoplasms
Middle Aged
Medical microbiology
Prognosis
3. Good health
medicine.anatomical_structure
030220 oncology & carcinogenesis
Hepatocellular carcinoma
Physical Sciences
Viruses
030211 gastroenterology & hepatology
Female
Anatomy
Pathogens
hormones
hormone substitutes
and hormone antagonists

Statistics (Mathematics)
Research Article
Adult
medicine.medical_specialty
Thyroid Hormones
Carcinoma
Hepatocellular

Endocrine Disorders
Endocrine System
Gastroenterology and Hepatology
Research and Analysis Methods
Thyroid function tests
Carcinomas
Microbiology
03 medical and health sciences
Hypothyroidism
Internal medicine
Gastrointestinal Tumors
medicine
Carcinoma
Biomarkers
Tumor

Humans
Statistical Methods
Thyroid-Stimulating Hormone
Aged
Retrospective Studies
Flaviviruses
business.industry
lcsh:R
Organisms
Viral pathogens
Biology and Life Sciences
Cancers and Neoplasms
Retrospective cohort study
Hepatocellular Carcinoma
Hepatology
medicine.disease
Hormones
Hepatitis viruses
Microbial pathogens
Multivariate Analysis
lcsh:Q
business
Mathematics
Hormone
Zdroj: PLoS ONE
PLoS ONE, Vol 12, Iss 8, p e0181878 (2017)
ISSN: 1932-6203
Popis: Background & aims Hypothyroidism has recently been proposed as predisposing factor for HCC development. However, the role of thyroid hormones (TH) in established HCC is largely unclear. We investigated the impact of TH on clinical characteristics and prognosis of HCC patients. Methods Of 838 patients diagnosed with nonsurgical HCC at the Division of Gastroenterology and Hepatology/Medical University of Vienna between 1992 and 2012, 667 patients fulfilled the inclusion criteria. The associations of thyroid function tests with patient, liver, and tumor characteristics as well as their impact on overall survival (OS) were investigated. Results Thyroid hormone substitution was more often observed in patients with low thyroid-stimulating hormone (TSH) concentration and in patients with elevated free tetraiodthyronine (fT4). Patients with high TSH (>3.77uU/ml) concentrations had larger tumors, while the opposite was true for patients with low TSH (1.66ng/dl) were more likely to have elevated CRP. While TSH was only associated with OS in univariate analysis (≤1.7 vs. >1.7uU/ml, median OS (95%CI), 12.3 (8.9–15.7 months) vs. 7.3 months (5.4–9.2 months); p = 0.003), fT4 (≤1.66 vs. >1.66ng/dl, median OS (95%CI), 10.6 (7.5–13.6 months) vs. 3.3 months (2.2–4.3 months); p = 0.007) remained an independent prognostic factor for OS (HR (95%CI) for fT4>1.66ng/dl, 2.1 (1.3–3.3); p = 0.002) in multivariate analysis. Conclusions TSH and fT4 were associated with prognostic factors of HCC (i.e., tumor size, CRP level). Elevated fT4 concentrations were independently associated with poor prognosis in HCC. Further studies are needed to characterize the role of TH in HCC in detail.
Databáze: OpenAIRE